1-(pyridin-4-ylmethyl)-3-(2-(3-(trifluoromethoxy)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-6-yl)urea

ID: ALA4873608

PubChem CID: 164623936

Max Phase: Preclinical

Molecular Formula: C20H15F3N6O2

Molecular Weight: 428.37

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(NCc1ccncc1)Nc1ccc2nc(-c3cccc(OC(F)(F)F)c3)nn2c1

Standard InChI:  InChI=1S/C20H15F3N6O2/c21-20(22,23)31-16-3-1-2-14(10-16)18-27-17-5-4-15(12-29(17)28-18)26-19(30)25-11-13-6-8-24-9-7-13/h1-10,12H,11H2,(H2,25,26,30)

Standard InChI Key:  AZUMPVOTKJTXOL-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
   36.0472  -21.5070    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.7549  -21.0984    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.4626  -21.5070    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.1767  -21.0942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.3395  -21.0984    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.7549  -20.2812    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.6318  -21.5070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9247  -21.0953    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.2174  -21.5032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.2170  -22.3213    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.9297  -22.7297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6340  -22.3194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.8794  -21.5044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.8816  -19.8710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.1699  -20.2777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.5892  -20.2817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.5859  -21.0984    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   40.3616  -21.3540    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   40.8444  -20.6952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.3670  -20.0326    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   41.6543  -20.6908    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.0591  -21.4008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.8755  -21.4005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.2844  -20.6920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.8709  -19.9822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.0558  -19.9860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.2764  -19.2728    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   44.0936  -19.2693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.4992  -18.5598    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   44.5052  -19.9752    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   44.9084  -19.2659    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  1  5  1  0
  2  6  2  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  4 13  2  0
  4 15  1  0
 13 17  1  0
 16 14  1  0
 14 15  2  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 16  2  0
 19 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 25 27  1  0
 27 28  1  0
 28 29  1  0
 28 30  1  0
 28 31  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4873608

    ---

Associated Targets(Human)

NAMPT Tchem Nicotinamide phosphoribosyltransferase (3221 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP1A2 Tchem Cytochrome P450 1A2 (26471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 428.37Molecular Weight (Monoisotopic): 428.1209AlogP: 4.01#Rotatable Bonds: 5
Polar Surface Area: 93.44Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.13CX Basic pKa: 5.02CX LogP: 5.00CX LogD: 5.00
Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.50Np Likeness Score: -2.15

References

1. Akiu M, Tsuji T, Sogawa Y, Terayama K, Yokoyama M, Tanaka J, Asano D, Sakurai K, Sergienko E, Sessions EH, Gardell SJ, Pinkerton AB, Nakamura T..  (2021)  Discovery of 1-[2-(1-methyl-1H-pyrazol-5-yl)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-3-(pyridin-4-ylmethyl)urea as a potent NAMPT (nicotinamide phosphoribosyltransferase) activator with attenuated CYP inhibition.,  43  [PMID:33887438] [10.1016/j.bmcl.2021.128048]

Source